A new 55mg prefilled syringe has been cleared to facilitate weight-based dosing for children weighing less than 40kg. The Food and Drug Administration (FDA) has expanded the approval of Skyrizi ® ...
Researchers report encouraging early results from a first-in-human clinical trial led by Children's National Hospital using a ...
Pediatric neurointerventional procedures are increasingly performed, yet antiplatelet management remains largely empirical or extrapolated from adult practice because of limited pediatric-specific ...
A mother-of-three who took her life with a shotgun had shown no suicidal intentions and "just snapped", her heartbroken family have said. The body of Rachel Chapman-Emms was found at her home in the ...
The FDA approved lebrikizumab-lbkz (EBGLYSS) for a maintenance dosing regimen of 250 mg every 8 weeks in adults and adolescents ≥12 years and ≥40 kg with moderate-to-severe atopic dermatitis, allowing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results